Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew J. Fromkin currently holds 7,061 shares of Immunovant, Inc. (IMVT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Fromkin has been a net seller of IMVT stock. They have purchased $43.5K and sold $1.0M worth of shares.
Andrew J. Fromkin's most recent insider trade was on Apr 7, 2026, when they sold 7,061 shares at $0.00 per share.
Andrew J. Fromkin serves as Executive at Immunovant, Inc. (IMVT). They have executed 17 insider transactions totaling $1.1M over their tenure at the company.
Andrew J. Fromkin holds the position of Executive at Immunovant, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Andrew J. Fromkin has shown a selling trading pattern, with $43.5K in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew J. Fromkin was on Dec 1, 2025, when they sold $447.8K worth of IMVT shares. This transaction involved 19,351 shares at $23.14 per share.
Andrew J. Fromkin currently owns 7,061 shares of Immunovant, Inc. (IMVT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew J. Fromkin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew J. Fromkin has 17 Form 4 filings on record as an insider at Immunovant, Inc..
Set alerts for Andrew J. Fromkin and 40,000+ other insiders.